Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-002 | Oct 31, 2023 | RX | Yes | No | 10,342,810 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biogen | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-003 | Oct 31, 2023 | RX | Yes | Yes | 11,236,121 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Biogen | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-002 | Oct 31, 2023 | RX | Yes | No | 10,172,871 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biogen | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-001 | Oct 31, 2023 | RX | Yes | No | 11,884,696 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biogen | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-003 | Oct 31, 2023 | RX | Yes | Yes | 9,512,165 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Biogen | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-002 | Oct 31, 2023 | RX | Yes | No | 9,512,165 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
